Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment (Q63613262)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment |
clinical trial |
Statements
A 3-arm, Multicenter, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of ADS-5102 Amantadine Extended Release Capsules in Multiple Sclerosis Patients With Walking Impairment (English)
0 references
29 March 2018
0 references
1 September 2019
0 references
540
0 references
18 year
0 references
70 year
0 references